On September 1, 2026 CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, reported that senior management will be participating in a fireside chat and investor meetings at the upcoming Wells Fargo 21st Annual Healthcare Conference being held in Boston on September 8 – 10, 2026.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Wells Fargo 21st Annual Healthcare Conference
Date: Wednesday, September 9, 2026
Time: 12:45pm EDT
Webcast: Click here
A replay of the fireside chat will also be available in the "Presentations and Events" page on the investor relations portion of the Company’s website at: www.cormedix.com
(Press release, CorMedix, SEP 1, 2026, View Source [SID1234670482])